Business Daily Media

Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate

  • Written by ACN Newswire - Press Releases

Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate

Tokyo and New York, Jun 18, 2021 - (JCN Newswire) - Eisai Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody drug conjugate (ADC).

MORAb-202 is Eisai's first ADC

Read more //?#

4 Tips For Protecting Your Business

If you own a business, the safety of yourself, your employees, your money, and your data is of utmost importance. Putting systems in place to prot...

Business Training

Why Should Your First Home Be a Custom Build?

Are you in the market for your first home? If so, you may be wondering if you should buy an existing home or build one from scratch. There are pro...

Property

3 Simple Ways to Earn More Dog Walking Clientele

A dog walking business can be very lucrative. Pet owners outside the house for significant periods lean on this service to care for their furry fr...

Business Training

Unveiling the Value: A Comprehensive Guide to Property Appraisals

Property appraisals serve as a critical foundation in the real estate industry. They facilitate an impartial assessment of a property's market val...

Property

Living in Central Coast NSW: Pros and Cons

Central Coast NSW is one of the most beautiful regions in Australia, with stunning beaches, national parks, and a laid-back lifestyle. However, li...

Property

What to Consider When Searching For a New Office Space

Plenty of signs can indicate that your current office space is not fit for purpose. You might have grown your business, downsized it, or realized ...

Business Training